BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 22677742)

  • 1. Adhesion molecule L1 is down-regulated in malignant peripheral nerve sheath tumors versus benign neurofibromatosis type 1-associated tumors.
    Blessmann M; Gröbe A; Quaas A; Kaifi JT; Mistakidis G; Bernreuther C; Sauter G; Gros S; Rawnaq T; Friedrich R; Mautner VF; Smeets R; Heiland M; Schachner M; Izbicki JR
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Feb; 113(2):239-44. PubMed ID: 22677742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.
    Lévy P; Vidaud D; Leroy K; Laurendeau I; Wechsler J; Bolasco G; Parfait B; Wolkenstein P; Vidaud M; Bièche I
    Mol Cancer; 2004 Jul; 3():20. PubMed ID: 15255999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX9 expression increases with malignant potential in tumors from patients with neurofibromatosis 1 and is not correlated to desert hedgehog.
    Carbonnelle-Puscian A; Vidal V; Laurendeau I; Valeyrie-Allanore L; Vidaud D; Bièche I; Leroy K; Lantieri L; Wolkenstein P; Schedl A; Ortonne N
    Hum Pathol; 2011 Mar; 42(3):434-43. PubMed ID: 21193222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors.
    Holtkamp N; Mautner VF; Friedrich RE; Harder A; Hartmann C; Theallier-Janko A; Hoffmann KT; von Deimling A
    Acta Neuropathol; 2004 Feb; 107(2):159-68. PubMed ID: 14673600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors.
    Beert E; Brems H; Daniëls B; De Wever I; Van Calenbergh F; Schoenaers J; Debiec-Rychter M; Gevaert O; De Raedt T; Van Den Bruel A; de Ravel T; Cichowski K; Kluwe L; Mautner V; Sciot R; Legius E
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1021-32. PubMed ID: 21987445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
    Friedrich RE; Keiner D; Hagel C
    Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of IRS2 in the progression from neurofibroma to malignant peripheral nerve sheath tumor.
    Shaw CM; Grobmyer SR; Ucar DA; Cance WG; Reith JD; Hochwald SN
    Anticancer Res; 2012 Feb; 32(2):439-43. PubMed ID: 22287730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation.
    Nielsen GP; Stemmer-Rachamimov AO; Ino Y; Moller MB; Rosenberg AE; Louis DN
    Am J Pathol; 1999 Dec; 155(6):1879-84. PubMed ID: 10595918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular profiles of neurofibromatosis type 1-associated plexiform neurofibromas: identification of a gene expression signature of poor prognosis.
    Lévy P; Bièche I; Leroy K; Parfait B; Wechsler J; Laurendeau I; Wolkenstein P; Vidaud M; Vidaud D
    Clin Cancer Res; 2004 Jun; 10(11):3763-71. PubMed ID: 15173083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis.
    Luscan A; Shackleford G; Masliah-Planchon J; Laurendeau I; Ortonne N; Varin J; Lallemand F; Leroy K; Dumaine V; Hivelin M; Borderie D; De Raedt T; Valeyrie-Allanore L; Larousserie F; Terris B; Lantieri L; Vidaud M; Vidaud D; Wolkenstein P; Parfait B; Bièche I; Massaad C; Pasmant E
    Clin Cancer Res; 2014 Jan; 20(2):358-71. PubMed ID: 24218515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors.
    Perry A; Roth KA; Banerjee R; Fuller CE; Gutmann DH
    Am J Pathol; 2001 Jul; 159(1):57-61. PubMed ID: 11438454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of emmprin and matrix metalloproteinases (MMPs) in peripheral nerve sheath tumors: emmprin and membrane-type (MT)1-MMP expressions are associated with malignant potential.
    Nabeshima K; Iwasaki H; Nishio J; Koga K; Shishime M; Kikuchi M
    Anticancer Res; 2006; 26(2B):1359-67. PubMed ID: 16619545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
    Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
    Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor, basic fibroblast growth factor and epithelial growth factor receptor in peripheral nerve sheath tumors of neurofibromatosis type 1.
    Friedrich RE; Beer C; Glatzel M; Hagel C
    Anticancer Res; 2015 Jan; 35(1):137-44. PubMed ID: 25550544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
    Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A
    Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent genomic imbalances in chromosomes 17, 19, and 22q in peripheral nerve sheath tumours detected by comparative genomic hybridization analysis.
    Koga T; Iwasaki H; Ishiguro M; Matsuzaki A; Kikuchi M
    J Pathol; 2002 May; 197(1):98-107. PubMed ID: 12081210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Culture of cytogenetically abnormal schwann cells from benign and malignant NF1 tumors.
    Wallace MR; Rasmussen SA; Lim IT; Gray BA; Zori RT; Muir D
    Genes Chromosomes Cancer; 2000 Feb; 27(2):117-23. PubMed ID: 10612798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cellular Retinoic Acid Binding Protein 2 Promotes Survival of Malignant Peripheral Nerve Sheath Tumor Cells.
    Fischer-Huchzermeyer S; Dombrowski A; Hagel C; Mautner VF; Schittenhelm J; Harder A
    Am J Pathol; 2017 Jul; 187(7):1623-1632. PubMed ID: 28502478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein D is down-regulated during malignant transformation of neurofibromas.
    Hunter S; Weiss S; Ou CY; Jaye D; Young A; Wilcox J; Arbiser JL; Monson D; Goldblum J; Nolen JD; Varma V
    Hum Pathol; 2005 Sep; 36(9):987-93. PubMed ID: 16153462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between benign and malignant peripheral nerve sheath tumors in NF1.
    Tucker T; Wolkenstein P; Revuz J; Zeller J; Friedman JM
    Neurology; 2005 Jul; 65(2):205-11. PubMed ID: 16043787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.